Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder
Sponsor: Asad Ullah Jan
Summary
This randomized controlled trial aims to compare the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Post-Traumatic Stress Disorder (PTSD). Adult patients diagnosed with PTSD will be randomly assigned to receive either EMDR therapy or SSRIs for a period of six weeks. The primary outcome is the rate of remission as measured by validated PTSD symptom severity scales at Week 6. Secondary outcomes include changes in functional impairment and patient-reported quality of life. The study seeks to determine whether EMDR therapy is a non-pharmacological alternative to SSRIs for achieving symptom remission in PTSD.
Official title: Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-05-06
Completion Date
2025-12-31
Last Updated
2025-07-09
Healthy Volunteers
No
Interventions
Eye Movement Desensitization and Reprocessing Therapy
Patients in this arm will receive weekly EMDR sessions for 6 weeks
Selective serotonin reuptake inhibitors
The patients will receive an SSRI medication daily for 6 weeks. The dose will be titrated by the clinician.
Locations (2)
Combined Military Hospital
Nowshera, KPK, Pakistan
Department of Psychiatry, Combined Military Hospital Nowshera
Nowshera, Kpk, Pakistan